Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study

Background: Although clinical trials documented omalizumab's efficacy in U.S. patients with chronic idiopathic urticaria (CIU), the real-world evidence on its long-term effectiveness is lacking. Objective: To assess omalizumab use and the long-term response in a large sample of U.S. real-world...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Allergy and asthma proceedings 2019-09, Vol.40 (5), p.321-328
Hauptverfasser:	Kavati, Abhishek, Zhdanava, Maryia, Ortiz, Benjamin, LeCocq, Jason, Schiffman, Bradd, Pilon, Dominic, Ching Cheung, Hoi, Lefebvre, Patrick, Stone, Brian D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Chronic Idiopathic Urticaria Chronic Spontaneous Urticaria Clinical trials Confidence intervals Dermatitis Disease Control Disease Course Electronic health records Electronic Medical Records Immunoglobulin E Immunotherapy Itching Monoclonal antibodies Omalizumab Patients Provider Assessment Pruritus Real-World Evidence Signs and symptoms Treatment Patterns Treatment Response Urticaria
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!